The cardiovascular, bone density, and cognitive benefits typically outweigh the risks for this population under proper physician supervision
Follow-up appointments are part of the standard care protocol, not optional add-ons
Obesity is the root cause of many chronic diseases including cardiovascular disease, the number one killer, but also diabetes, liver and kidney disease
[,] The pharmacokinetics of GLP-1 influence dosing regimens and suitability for GDM treatment
10.3233/JAD-170349 49 ChupelM
Related insights on how GLP-1 treatment options are evolving are also discussed here: Aria Walker on Disclaimer: This blog is intended for general informational purposes only and does not constitute or substitute for professional medical advice, diagnosis, or treatment